NPI: 1073580726 · PLAINVIEW, TX 79072 · General Acute Care Hospital · NPI assigned 03/01/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 03/01/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 612 | $25K |
| 2021 | 14,441 | $869K |
| 2022 | 29,983 | $1.67M |
| 2023 | 30,636 | $986K |
| 2024 | 12,520 | $449K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,563 | 2,370 | $883K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,498 | 3,406 | $760K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,938 | 11,948 | $702K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,453 | 1,335 | $364K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,865 | 1,833 | $135K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,817 | 7,485 | $128K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,294 | 1,268 | $111K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,922 | 7,902 | $78K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,745 | 2,660 | $62K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 875 | 861 | $58K |
| 71045 | Radiologic examination, chest; single view | 903 | 847 | $57K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,041 | 996 | $56K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,283 | 1,241 | $51K |
| 80053 | Comprehensive metabolic panel | 5,076 | 4,496 | $36K |
| 36415 | Collection of venous blood by venipuncture | 9,467 | 7,897 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 221 | 208 | $34K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,094 | 1,068 | $33K |
| 87081 | 2,689 | 2,622 | $32K | |
| 86780 | 1,070 | 1,011 | $31K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,490 | 1,429 | $27K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 325 | 311 | $25K |
| 87634 | 187 | 185 | $21K | |
| 81002 | 2,316 | 1,591 | $20K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 191 | 171 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 191 | 171 | $17K |
| 87420 | 648 | 626 | $16K | |
| 87150 | 170 | 166 | $15K | |
| 87070 | 651 | 629 | $15K | |
| CP007 | 77 | 48 | $14K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 101 | 96 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 966 | 880 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 581 | 542 | $11K |
| 81003 | 3,019 | 2,125 | $9K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 111 | 108 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 37 | 37 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 29 | 28 | $7K |
| 84144 | 87 | 80 | $6K | |
| 81025 | 376 | 357 | $5K | |
| 0353U | 105 | 102 | $5K | |
| 87660 | 86 | 74 | $5K | |
| 86803 | 111 | 106 | $4K | |
| 86762 | 86 | 82 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,062 | 1,041 | $4K |
| 86850 | 118 | 111 | $4K | |
| 87510 | 100 | 86 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 12 | 12 | $3K |
| 87480 | 101 | 86 | $3K | |
| 82947 | 371 | 352 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 138 | 122 | $3K |
| 87340 | 102 | 97 | $3K | |
| 81001 | 1,161 | 1,041 | $3K | |
| 73130 | 17 | 16 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12 | 12 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 126 | 125 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 257 | 73 | $2K |
| 80061 | Lipid panel | 828 | 809 | $2K |
| 73560 | 13 | 12 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 44 | 37 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 252 | 224 | $1K |
| 87077 | 104 | 101 | $1K | |
| 84439 | 219 | 216 | $1K | |
| 84702 | 31 | 25 | $1K | |
| 81000 | 204 | 177 | $1K | |
| 86900 | 131 | 124 | $968.04 | |
| 86901 | 131 | 124 | $951.59 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 61 | 57 | $921.92 |
| 96375 | Therapeutic injection; each additional sequential IV push | 126 | 108 | $827.85 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 26 | 25 | $806.87 |
| 82950 | 80 | 77 | $805.23 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 73 | 25 | $792.84 |
| 80048 | Basic metabolic panel (calcium, ionized) | 851 | 767 | $759.52 |
| 82728 | 33 | 29 | $681.39 | |
| 83735 | 107 | 105 | $631.26 | |
| 82951 | 29 | 25 | $420.59 | |
| 84484 | 282 | 206 | $350.23 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 15 | 12 | $268.81 |
| 83690 | 88 | 81 | $209.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 70 | 65 | $201.54 |
| 83880 | 110 | 97 | $153.79 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 13 | 13 | $90.56 |
| 82150 | 19 | 16 | $61.70 | |
| 86140 | 27 | 25 | $33.07 | |
| 85610 | 104 | 92 | $26.91 | |
| 85380 | 12 | 12 | $13.94 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 426 | 321 | $0.04 |
| A9270 | Non-covered item or service | 259 | 177 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 13 | 13 | $0.00 |
| 83605 | 54 | 38 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12 | 12 | $0.00 |
| 80164 | 13 | 12 | $0.00 |